1 October 2012 in International Journal of Oral and Maxillofacial Surgery
24 May 2018 in Quality of Life Research
EMEdnele Fabyene Primo Miranda
Ednele Fabyene Primo Miranda
1 January 2017 in Anesthesia Progress
CSCássio Roberto Rocha dos Santos
Cássio Roberto Rocha dos Santos
MPMarcos Luciano Pimenta Pinheiro
Marcos Luciano Pimenta Pinheiro
The aim of the present study was to assess the effectiveness of preemptive dexamethasone in surgery of the lower third molars and to compare it with other oral anti-inflammatories. An electronic search was conducted for preemptive effects related to lower third-molar surgery in 3 separate databases. The variables pain, swelling, and trismus were assessed. Meta-analysis was used to calculate the pooled effect measures for mean and standard deviation values (95% confidence interval [CI]). Seven split-mouth clinical trials were selected. Two studies were included in the meta-analysis. Three studies showed a low risk of bias; 2 studies exhibited a moderate risk and 2 a high risk of bias. Dexamethasone was better than nonsteroidal anti-inflammatories for preemptive effectiveness. Meta-analysis for swelling confirmed better results for dexamethasone than for methylprednisolone after 2 days (95% CI = −1.28 to −0.38), 4 days (95% CI = −1.65 to −0.71), 7 days (95% CI = −1.42 to −0.71), and overall (95% CI = −1.25 to −0.72). Dexamethasone was better than methylprednisolone for mouth opening after 4 days (95% CI = 0.18 to 1.07). There is insufficient evidence through meta-analysis to conclude that dexamethasone is better than other nonsteroidal anti-inflammatories or methylprednisolone as a preemptive analgesic. The results of this meta-analysis suggest that dexamethasone is more effective than methylprednisolone for swelling and trismus.
1 November 2019 in Archives of Oral Biology
1 August 2014 in Dental Press Journal of Orthodontics
MRMaria Letícia Ramos-Jorge
Maria Letícia Ramos-Jorge
OBJECTIVE: The aim of the present systematic review was to determine the existence of scientific evidence demonstrating the effectiveness of orofacial myofunctional therapy (OMT) as an adjuvant to orthodontic treatment in individuals with orofacial disorders. A further aim was to assess the methodological quality of the studies included in the review. METHODS: An electronic search was performed in eight databases (Medline, BBO, LILACS, Web of Science, EMBASE, BIREME, Cochrane Library and SciELO) for papers published between January 1965 and March 2011, with no language restrictions. Selection of articles and data extraction were performed by two independent researchers. The quality of the selected articles was also assessed. RESULTS: Search strategy resulted in the retrieval of 355 publications, only four of which fulfilled the eligibility criteria and qualified for final analysis. All papers selected had a high risk of bias. CONCLUSIONS: The findings of the present systematic review demonstrate the scarcity of consistent studies and scientific evidence supporting the use of OMT in combination with orthodontic treatment to achieve better results in the correction of dentofacial disorders in individuals with orofacial abnormalities.
20 February 2019 in Journal of Maxillofacial and Oral Surgery
APAna Cláudia Rocha Protásio
Ana Cláudia Rocha Protásio